About Stemcells

Stem Cell derived from Umbilical Cord is the hope for cure for two specific groups of diseases - blood cancers and Thalassemia.

Awareness about marrow or blood stem cell transplantation, widely recognized in the developed countries as the treatment of choice for leukemia, lymphoma and 70 other related diseases, is slowly spreading to the developing world, including India. 

About 3 million Indians are diagnosed with cancer, between 5% and 10% of them with blood cancers. Similarly approximately 10,000 children are born every year with Thalassemia in India. For many such patients, peripheral blood stem cell or umbilical cord derives stem cell transplantation offers the only hope.

Cord blood is the blood that remains in the umbilical cord after a delivery of the baby. This blood is usually discarded. This blood has been identified as one of the richest sources of stem cells that could be used to effectively treat a variety of diseases and help research in regenerative medicine.

Mission: To serve as a source of stem cells collected from umbilical cord blood for treatment of leukemia and related disorders, and to serve the needs of medical research.

Vision: Jeevan seeks to link India to the global network of stem cell and cord blood registries that serve as sources of stem cells. Jeevan believes stem cell transplantation represents a potentially life saving treatment option for thousands of patients with otherwise fatal blood and immune system disorders. Jeevan seeks to bring the advanced medicine of unrelated stem cell transplantation to India, by providing access to stem cells, initially using umbilical cord blood and eventually establishing a full-fledged, adult stem cell donor registry, similar to the registries in most developed countries.
 
Being in the domain of blood banking for the past 12 years, Jeevan proposes:

For any clarifications please contact 97908 97918, 2835 1200 in Chennai or email stemcell@jeevan.org